UK-RNQD-220099. DOP: June 2022.
Resources for HCPs
RINVOQ Initiation Guide
This initiation guide has been created for reference before starting patients on RINVOQ.
Resources for your patients
Patient Booklet for Adults
This guide has been designed to help your adult patients navigate their RINVOQ journey step-by-step.
Patient Booklet for Adolescents
This guide has been designed to help adolescent patients navigate their RINVOQ journey step-by-step.
RINVOQ Patient Alert Card
This contains important information for your patients and their carers. The Patient Alert Card must always be sent to the patient along with the Patient Guide.
Printed Materials
For patients who prefer not to receive information digitally, all of the items are available as hard copy materials.
To receive printed versions of any of these materials for your patients, submit your details on the Contact Us page.
1. RINVOQ Summary of Product Characteristics
UK-RNQD-220107. Date of preparation: May 2022
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores.
Adverse events should also be reported to AbbVie on GBPV@abbvie.com
